📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Design and Synthesis of Novel Aminoindazole-pyrrolo[2,3-b]pyridine Inhibitors of IKKa That Selectively Perturb Cellular Non-Canonical NF-?B Signalling. (2024)

First Author: Riley C

Attributed to: First-in-class Selective IKKalpha Inhibitors for the Treatment of Castrate Resistant Prostate Cancer (CRPC) and Pancreatic Cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/molecules29153515

PubMed Identifier: 39124921

Publication URI: http://europepmc.org/abstract/MED/39124921

Type: Journal Article/Review

Volume: 29

Parent Publication: Molecules (Basel, Switzerland)

Issue: 15

ISSN: 1420-3049